The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell, D. A.
Right arrow Articles by Botto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, D. A.
Right arrow Articles by Botto, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 1999, 162: 5676-5679.
Copyright © 1999 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: C1q Protects Against the Development of Glomerulonephritis Independently of C3 Activation1

Daniel A. Mitchell2,*, Philip R. Taylor2,*, H. Terence Cook{dagger}, Jill Moss{ddagger}, Anne E. Bygrave*, Mark J. Walport* and Marina Botto3,*

* Rheumatology Section and {dagger} Department of Histopathology, Hammersmith Campus, Imperial College School of Medicine, London, United Kingdom; and {ddagger} Department of Histopathology, Charing Cross Campus, Imperial College School of Medicine, London, United Kingdom

C1q-deficient (C1qa-/-) mice develop antinuclear Abs and glomerulonephritis (GN) characterized by multiple apoptotic bodies. To explore the contribution of C3 activation to the induction of spontaneous GN, C1qa-/- mice were crossed with factor B- and C2-deficient (H2-Bf/C2-/-) mice. GN was present in 64% of the 45 C1qa/H2-Bf/C2-/- mice compared with 8% of the 65 H2-Bf/C2-/- mice and none of the 24 wild-type controls. IgG was detected in the glomeruli of diseased C1qa/H2-Bf/C2-/- kidneys. However, glomerular staining for C3 was absent. Increased numbers of glomerular apoptotic bodies were detected in undiseased C1qa/H2-Bf/C2-/- kidneys. These findings support the hypothesis that C1q may play a role in the clearance of apoptotic cells without the necessity for C3 activation and demonstrate that the activation of C3 is not essential for the development of GN in this spontaneous model of lupus-like disease.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Chen, Y.-B. Park, E. Patel, and G. J. Silverman
IgM Antibodies to Apoptosis-Associated Determinants Recruit C1q and Enhance Dendritic Cell Phagocytosis of Apoptotic Cells
J. Immunol., May 15, 2009; 182(10): 6031 - 6043.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. S. Sheerin, K. Abe, P. Risley, and S. H. Sacks
Accumulation of Immune Complexes in Glomerular Disease Is Independent of Locally Synthesized C3
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 686 - 696.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Bijl, E Reefman, G Horst, P C Limburg, and C G M Kallenberg
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
Ann Rheum Dis, January 1, 2006; 65(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Quigg
Complement and the Kidney
J. Immunol., October 1, 2003; 171(7): 3319 - 3324.
[Full Text] [PDF]


Home page
J. Immunol.Home page
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid
Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains
J. Immunol., July 15, 2003; 171(2): 812 - 820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Mitchell, M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport
C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression
J. Immunol., March 1, 2002; 168(5): 2538 - 2543.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Einav, O. O. Pozdnyakova, M. Ma, and M. C. Carroll
Complement C4 Is Protective for Lupus Disease Independent of C3
J. Immunol., February 1, 2002; 168(3): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. I. Fonseca, P. M. Carpenter, M. Park, G. Palmarini, E. L. Nelson, and A. J. Tenner
C1qRP, a myeloid cell receptor in blood, is predominantly expressed on endothelial cells in human tissue
J. Leukoc. Biol., November 1, 2001; 70(5): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Robson, H. T. Cook, M. Botto, P. R. Taylor, N. Busso, R. Salvi, C. D. Pusey, M. J. Walport, and K. A. Davies
Accelerated Nephrotoxic Nephritis Is Exacerbated in C1q-Deficient Mice
J. Immunol., June 1, 2001; 166(11): 6820 - 6828.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Sekine, C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson
Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice
J. Immunol., May 15, 2001; 166(10): 6444 - 6451.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Kamradt and N. A. Mitchison
Tolerance and Autoimmunity
N. Engl. J. Med., March 1, 2001; 344(9): 655 - 664.
[Full Text] [PDF]


Home page
JEMHome page
Z. Chen, S. B. Koralov, and G. Kelsoe
Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2
J. Exp. Med., November 6, 2000; 192(9): 1339 - 1352.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. R. Taylor, A. Carugati, V. A. Fadok, H. T. Cook, M. Andrews, M. C. Carroll, J. S. Savill, P. M. Henson, M. Botto, and M. J. Walport
A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo
J. Exp. Med., August 7, 2000; 192(3): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. C. Pickering and M. J. Walport
Links between complement abnormalities and systemic lupus erythematosus
Rheumatology, February 1, 2000; 39(2): 133 - 141.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Salmon and C. Gordon
The role of apoptosis in systemic lupus erythematosus
Rheumatology, December 1, 1999; 38(12): 1177 - 1183.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.